share_log

4: Statement of changes in beneficial ownership of securities-Director Allen Charles W

SEC announcement ·  May 21 20:20
Summary by Moomoo AI
On May 16, 2024, Charles W. Allen, associated with 60 Degrees Pharmaceuticals, completed a purchase of 4,000 shares of the company's common stock. The transaction was executed at a price of $0.223 per share. Following this acquisition, Allen's direct holdings in the company increased to a total of 14,000 shares. The transaction is categorized as an exercise or conversion of derivative security, and it reflects Allen's growing stake in the pharmaceutical company.
On May 16, 2024, Charles W. Allen, associated with 60 Degrees Pharmaceuticals, completed a purchase of 4,000 shares of the company's common stock. The transaction was executed at a price of $0.223 per share. Following this acquisition, Allen's direct holdings in the company increased to a total of 14,000 shares. The transaction is categorized as an exercise or conversion of derivative security, and it reflects Allen's growing stake in the pharmaceutical company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more